{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:58:28Z","timestamp":1793703508021,"version":"4.5.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11910-023-01313-y","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T07:02:08Z","timestamp":1697871728000},"page":"751-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neurological Complications Associated with Hereditary Bleeding Disorders"],"prefix":"10.1007","volume":"23","author":[{"given":"Muhammad Qasim","family":"Bhatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel","family":"Gonzalez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin A.","family":"Divani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Hinduja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne H.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/B978-0-7020-4087-0.00070-X","volume":"120","author":"C Amin","year":"2014","unstructured":"Amin C, Sharathkumar A, Griest A. Bleeding diathesis and hemophilias. Handb Clin Neurol. 2014;120:1045\u201359. https:\/\/doi.org\/10.1016\/B978-0-7020-4087-0.00070-X.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"1313_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2141.2007.06949.x","volume":"140","author":"RC Ljung","year":"2008","unstructured":"Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008;140(4):378\u201384. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06949.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"1313_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000216333","volume":"22","author":"PM de Tezanos","year":"1992","unstructured":"de Tezanos PM, Fernandez J, Perez Bianco PR. Update of 156 episodes of central nervous system bleeding in hemophiliacs. Haemostasis. 1992;22(5):259\u201367. https:\/\/doi.org\/10.1159\/000216333.","journal-title":"Haemostasis."},{"issue":"6","key":"1313_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1182\/blood.V51.6.1179.1179","volume":"51","author":"ME Eyster","year":"1978","unstructured":"Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR. Central nervous system bleeding in hemophiliacs. Blood. 1978;51(6):1179\u201388.","journal-title":"Blood."},{"issue":"8","key":"1313_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.7326\/M19-1208","volume":"171","author":"A Iorio","year":"2019","unstructured":"Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, et al. Data and Demographics Committee of the World Federation of Hemophilia. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med. 2019;171(8):540\u20136. https:\/\/doi.org\/10.7326\/M19-1208.","journal-title":"Ann Intern Med"},{"issue":"6694","key":"1313_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/29325","volume":"394","author":"ML Kahn","year":"1998","unstructured":"Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, et al. A dual thrombin receptor system for platelet activation. Nature. 1998;394(6694):690\u20134. https:\/\/doi.org\/10.1038\/29325.","journal-title":"Nature."},{"issue":"6","key":"1313_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1172\/JCI117586","volume":"94","author":"H Kojima","year":"1994","unstructured":"Kojima H, Newton-Nash D, Weiss HJ, Zhao J, Sims PJ, Wiedmer T. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest. 1994;94(6):2237\u201344. https:\/\/doi.org\/10.1172\/JCI117586.","journal-title":"J Clin Invest"},{"issue":"7","key":"1313_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/s-0032-1326786","volume":"38","author":"MD Carcao","year":"2012","unstructured":"Carcao MD. The diagnosis and management of congenital hemophilia. Semin Thromb Hemost. 2012;38(7):727\u201334. https:\/\/doi.org\/10.1055\/s-0032-1326786.","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"1313_CR9","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/jth.12672","volume":"12","author":"VS Blanchette","year":"2014","unstructured":"Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935\u20139. https:\/\/doi.org\/10.1111\/jth.12672.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1313_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/hae.13891","volume":"26","author":"S Raso","year":"2020","unstructured":"Raso S, Lambert C, Boban A, Napolitano M, Siragusa S, Hermans C. Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia? Haemophilia. 2020;26(1):117\u201321. https:\/\/doi.org\/10.1111\/hae.13891.","journal-title":"Haemophilia."},{"issue":"4","key":"1313_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-0734.2001.00049.x","volume":"5","author":"LN Boggio","year":"2001","unstructured":"Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol. 2001;5(4):389\u2013404; quiz following 431. https:\/\/doi.org\/10.1046\/j.1468-0734.2001.00049.x.","journal-title":"Rev Clin Exp Hematol"},{"issue":"12","key":"1313_CR12","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1111\/jth.14315","volume":"16","author":"M Makris","year":"2018","unstructured":"Makris M, Oldenburg J, Mauser-Bunschoten EP, Peerlinck K, Castaman G. Fijnvandraat K; subcommittee on Factor VIII, Factor IX and Rare Bleeding Disorders. The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH. J Thromb Haemost. 2018;16(12):2530\u20133. https:\/\/doi.org\/10.1111\/jth.14315.","journal-title":"J Thromb Haemost"},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-0716-3175-1_37","volume":"2663","author":"S Abraham","year":"2023","unstructured":"Abraham S, Duncan EM. A review of factor VIII and factor IX assay methods for monitoring extended half-life products in hemophilia A and B. Methods Mol Biol. 2023;2663:569\u201388. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_37.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1313_CR14","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/jth.14784","volume":"18","author":"F Peyvandi","year":"2020","unstructured":"Peyvandi F, Kenet G, Pekrul I, Pruthi RK, Ramge P, Spannagl M. Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assays. J Thromb Haemost. 2020;18(6):1242\u201355. https:\/\/doi.org\/10.1111\/jth.14784.","journal-title":"J Thromb Haemost"},{"issue":"26","key":"1313_CR15","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1182\/blood.2021011849","volume":"138","author":"AF Zwagemaker","year":"2021","unstructured":"\u2022\u2022 Zwagemaker AF, Gouw SC, Jansen JS, Vuong C, Coppens M, Hu Q, Feng X, Kim SK, Van der Bom JG, Fijnvandraat K. Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis. Blood. 2021;138(26):2853\u201373. https:\/\/doi.org\/10.1182\/blood.2021011849. The above study was the major systematic review and metanalysis conducted to gather all evidence available to estimate ICH burden among hemophilia patients.","journal-title":"Blood"},{"issue":"2","key":"1313_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/hae.13081","volume":"23","author":"R Kulkarni","year":"2017","unstructured":"Kulkarni R, Presley RJ, Lusher JM, Shapiro AD, Gill JC, Manco-Johnson M, et al. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System. Haemophilia. 2017;23(2):207\u201314. https:\/\/doi.org\/10.1111\/hae.13081.","journal-title":"Haemophilia."},{"issue":"Suppl 3","key":"1313_CR17","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1007\/pl00014346","volume":"158","author":"J Klinge","year":"1999","unstructured":"Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-K\u00f6rholz C, Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr. 1999;158(Suppl 3):S162\u20135. https:\/\/doi.org\/10.1007\/pl00014346.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1313_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2141.2011.08967.x","volume":"156","author":"M Richards","year":"2012","unstructured":"Richards M, Lavigne Lissalde G, Combescure C, Batorova A, Dolan G, Fischer K, et al. European Haemophilia Treatment and Standardization Board. Neonatal bleeding in haemophilia: a European cohort study. Br J Haematol. 2012;156(3):374\u201382. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08967.x.","journal-title":"Br J Haematol"},{"issue":"4","key":"1313_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2141.2007.06949.x","volume":"140","author":"RC Ljung","year":"2008","unstructured":"Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008;140(4):378\u201384. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06949.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"1313_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1046\/j.1365-2516.1999.00338.x","volume":"5","author":"MD Nelson Jr","year":"1999","unstructured":"Nelson MD Jr, Maeder MA, Usner D, Mitchell WG, Fenstermacher MJ, Wilson DA, et al. Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. The Hemophilia Growth and Development Study. Haemophilia. 1999;5(5):306\u201312. https:\/\/doi.org\/10.1046\/j.1365-2516.1999.00338.x.","journal-title":"Haemophilia."},{"issue":"2","key":"1313_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2141.2010.08469.x","volume":"152","author":"C Witmer","year":"2011","unstructured":"\u2022 Witmer C, Presley R, Kulkarni R, Soucie JM, Manno CS, Raffini L. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. Br J Haematol. 2011;152(2):211\u20136. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08469.x. Nested case-control study investigating risk factors associated with ICH. This was the first study that demonstrated prescribed prophylaxis showed a protective effect against ICH in patients with severe hemophilia.","journal-title":"Br J Haematol"},{"issue":"5","key":"1313_CR22","doi-asserted-by":"publisher","first-page":"e20173485","DOI":"10.1542\/peds.2017-3485","volume":"141","author":"JD Anderst","year":"2018","unstructured":"Anderst JD, Carpenter SL, Presley R, Berkoff MC, Wheeler AP, Sidonio RF Jr, et al. Relevance of abusive head trauma to intracranial hemorrhages and bleeding disorders. Pediatrics. 2018;141(5):e20173485. https:\/\/doi.org\/10.1542\/peds.2017-3485.","journal-title":"Pediatrics."},{"issue":"1","key":"1313_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajh.1146","volume":"68","author":"R Nuss","year":"2001","unstructured":"Nuss R, Soucie JM. Evatt B; Hemophilia Surveillance System Project Investigators. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol. 2001;68(1):37\u201342. https:\/\/doi.org\/10.1002\/ajh.1146.","journal-title":"Am J Hematol"},{"issue":"1","key":"1313_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2516.2011.02611.x","volume":"18","author":"E Zanon","year":"2012","unstructured":"\u2022 Zanon E, Iorio A, Rocino A, Artoni A, Santoro R, et al. Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia. 2012;18(1):39\u201345. https:\/\/doi.org\/10.1111\/j.1365-2516.2011.02611.x. The association of Italian hemophilia centers conducted a retrospective survey from 1987 to 2008 investigating the location of CNS bleeds, pertinent risk factors for ICH, and treatment modalities.","journal-title":"Haemophilia"},{"issue":"2","key":"1313_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000022418","volume":"28","author":"S Arkin","year":"1998","unstructured":"Arkin S, Cooper HA, Hutter JJ, Miller S, Schmidt ML, Seibel NL, et al. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program. Haemostasis. 1998;28(2):93\u20138. https:\/\/doi.org\/10.1159\/000022418.","journal-title":"Haemostasis."},{"issue":"4","key":"1313_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2516.2006.01297.x","volume":"12","author":"M Franchini","year":"2006","unstructured":"Franchini M, Girelli D, Olivieri O, Castaman G, Lippi G, Poli G, et al. Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild\/moderate haemophilia A. Haemophilia. 2006;12(4):448\u201351. https:\/\/doi.org\/10.1111\/j.1365-2516.2006.01297.x.","journal-title":"Haemophilia."},{"issue":"4","key":"1313_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12288-016-0637-3","volume":"32","author":"JY Cho","year":"2016","unstructured":"Cho JY, Lee WS, Park YS, Lee SH, Koh JS. Clinical characteristics and prognostic factors in hemophiliacs with intracranial hemorrhage: a single-center, retrospective experience. Indian J Hematol Blood Transfus. 2016;32(4):488\u201393. https:\/\/doi.org\/10.1007\/s12288-016-0637-3. Epub 2016 Jan 12","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"6","key":"1313_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1182\/blood.V51.6.1179.1179","volume":"51","author":"ME Eyster","year":"1978","unstructured":"Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR. Central nervous system bleeding in hemophiliacs. Blood. 1978;51(6):1179\u201388.","journal-title":"Blood."},{"issue":"6","key":"1313_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/ijlh.12877","volume":"40","author":"DM Adcock","year":"2018","unstructured":"Adcock DM, Strandberg K, Shima M, Marlar RA. Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B. Int J Lab Hematol. 2018;40(6):621\u20139. https:\/\/doi.org\/10.1111\/ijlh.12877.","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"1313_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1055\/s-0038-1648879","volume":"72","author":"S Schulman","year":"1994","unstructured":"Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Monoclonal purified FVIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost. 1994;72(3):403\u20137.","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"1313_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000204025","volume":"94","author":"UP Martinowitz","year":"1995","unstructured":"Martinowitz UP, Schulman S. Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B. Acta Haematol. 1995;94(Suppl 1):35\u201342. https:\/\/doi.org\/10.1159\/000204025.","journal-title":"Acta Haematol"},{"issue":"Suppl 1","key":"1313_CR32","first-page":"S15","volume":"7","author":"CR Hay","year":"1996","unstructured":"Hay CR, Doughty HI, Savidge GF. Continuous infusion of factor VIII for surgery and major bleeding. Blood Coagul Fibrinolysis. 1996;7(Suppl 1):S15\u20139.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"1313_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/hae.13331","volume":"24","author":"PA Holme","year":"2018","unstructured":"Holme PA, Tj\u00f8nnfjord GE, Batorova A. Continuous infusion of coagulation factor concentrates during intensive treatment. Haemophilia. 2018;24(1):24\u201332. https:\/\/doi.org\/10.1111\/hae.13331.","journal-title":"Haemophilia."},{"issue":"6","key":"1313_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2141.2005.05952.x","volume":"132","author":"PH Bolton-Maggs","year":"2006","unstructured":"Bolton-Maggs PH. Optimal haemophilia care versus the reality. Br J Haematol. 2006;132(6):671\u201382. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05952.x.","journal-title":"Br J Haematol"},{"issue":"Suppl 6","key":"1313_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"\u2022\u2022 Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH guidelines for the management of hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1\u2013158. https:\/\/doi.org\/10.1111\/hae.14046. Epub 2020 Aug 3. Erratum in: Haemophilia. 2021;27(4):699. The latest World Federation of hemophilia guidelines outlining practice patterns and management strategies.","journal-title":"Haemophilia"},{"issue":"5","key":"1313_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/MEJ.0000000000000094","volume":"21","author":"MA Rivera-N\u00fa\u00f1ez","year":"2014","unstructured":"Rivera-N\u00fa\u00f1ez MA, Borobia AM, Garc\u00eda-Erce JA. Mart\u00ed de Gracia M, P\u00e9rez-Perilla P, Quintana-D\u00edaz M. Acute complications and outcomes of acute head injury in adult patients with haemophilia. Eur J Emerg Med. 2014;21(5):380\u20133. https:\/\/doi.org\/10.1097\/MEJ.0000000000000094.","journal-title":"Eur J Emerg Med"},{"issue":"5","key":"1313_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2450\/2019.0253-18","volume":"17","author":"E Zanon","year":"2019","unstructured":"\u2022 Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus. 2019;17(5):378\u201384. https:\/\/doi.org\/10.2450\/2019.0253-18. Literature review published within the last 5 years, that thoroughly investigated pertinent risk factors for ICH in hemophilia patients, with particular emphasis on early symptoms and prophylaxis.","journal-title":"Blood Transfus"},{"issue":"5","key":"1313_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjh.17580","volume":"194","author":"H Fassel","year":"2021","unstructured":"Fassel H, McGuinn C. Haemophilia: factoring in new therapies. Br J Haematol. 2021;194(5):835\u201350. https:\/\/doi.org\/10.1111\/bjh.17580. Epub 2021 Jul 28","journal-title":"Br J Haematol"},{"issue":"4","key":"1313_CR39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1538-7836.2011.04214.x","volume":"9","author":"A Gringeri","year":"2011","unstructured":"Gringeri A, Lundin B, von Mackensen S, Mantovani L, Mannucci PM, ESPRIT Study Group. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). J Thromb Haemost. 2011;9(4):700\u201310. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04214.x.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1313_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMoa067659","volume":"357","author":"MJ Manco-Johnson","year":"2007","unstructured":"Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535\u201344. https:\/\/doi.org\/10.1056\/NEJMoa067659.","journal-title":"N Engl J Med"},{"issue":"6","key":"1313_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/jth.12202","volume":"11","author":"MJ Manco-Johnson","year":"2013","unstructured":"Manco-Johnson MJ, Kempton CL, Reding MT, Lissitchkov T, Goranov S, Gercheva L, et al. Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART). J Thromb Haemost. 2013;11(6):1119\u201327. https:\/\/doi.org\/10.1111\/jth.12202. Erratum in: J Thromb Haemost 2014 Jan;12(1):119-22","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1313_CR42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jth.12828","volume":"13","author":"K Kavakli","year":"2015","unstructured":"Kavakli K, Yang R, Rusen L, Beckmann H, Tseneklidou-Stoeter D. Maas Enriquez M; LEOPOLD II Study Investigators. Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II). J Thromb Haemost. 2015;13(3):360\u20139. https:\/\/doi.org\/10.1111\/jth.12828.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1313_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/bjh.14844","volume":"179","author":"NG Andersson","year":"2017","unstructured":"\u2022\u2022 Andersson NG, Auerswald G, Barnes C, et al. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment. Br J Haematol. 2017;179(2):298\u2013307. https:\/\/doi.org\/10.1111\/bjh.14844. Landmark trial investigating prophylactic treatment among hemophilia patients for ICH.","journal-title":"Br J Haematol"},{"issue":"23","key":"1313_CR44","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1182\/blood-2017-08-801662","volume":"130","author":"PJ Lenting","year":"2017","unstructured":"Lenting PJ, Denis CV, Christophe OD. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII? Blood. 2017;130(23):2463\u20138. https:\/\/doi.org\/10.1182\/blood-2017-08-801662.","journal-title":"Blood."},{"issue":"9","key":"1313_CR45","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1703068","volume":"377","author":"J Oldenburg","year":"2017","unstructured":"\u2022 Oldenburg J, Mahlangu JN, Kim B, Schmitt C, Callaghan MU, Young G, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Valente N, Asikanius E, Levy GG, Windyga J, Shima M. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med. 2017;377(9):809\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1703068. The first study investigating the use of emicizumab as an effective prophylactic agent in hemophilia A (HAVEN 1).","journal-title":"N Engl J Med"},{"issue":"24","key":"1313_CR46","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood.2019001869","volume":"134","author":"G Young","year":"2019","unstructured":"Young G, Liesner R, Chang T, Sidonio R, Oldenburg J, Jim\u00e9nez-Yuste V, et al. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors. Blood. 2019;134(24):2127\u201338. https:\/\/doi.org\/10.1182\/blood.2019001869.","journal-title":"Blood."},{"issue":"9","key":"1313_CR47","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa1803550","volume":"379","author":"J Mahlangu","year":"2018","unstructured":"Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso ME, et al. Emicizumab prophylaxis in patients who have hemophilia A without inhibitors. N Engl J Med. 2018;379(9):811\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1803550.","journal-title":"N Engl J Med"},{"issue":"24","key":"1313_CR48","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood.2019001869","volume":"134","author":"G Young","year":"2019","unstructured":"Young G, Liesner R, Chang T, Sidonio R, Oldenburg J, Jim\u00e9nez-Yuste V, et al. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors. Blood. 2019;134(24):2127\u201338. https:\/\/doi.org\/10.1182\/blood.2019001869.","journal-title":"Blood."},{"issue":"2","key":"1313_CR49","doi-asserted-by":"publisher","first-page":"e12670","DOI":"10.1002\/rth2.12670","volume":"6","author":"R Yang","year":"2022","unstructured":"Yang R, Wang S, Wang X, Sun J, Chuansumrit A, Zhou J, et al. Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5). Res Pract Thromb Haemost. 2022;6(2):e12670. https:\/\/doi.org\/10.1002\/rth2.12670.","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"1313_CR50","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S2352-3026(22)00377-5","volume":"10","author":"C N\u00e9grier","year":"2023","unstructured":"N\u00e9grier C, Mahlangu J, Lehle M, Chowdary P, Catalani O, Bernardi RJ, et al. Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Lancet Haematol. 2023;10(3):e168\u201377. https:\/\/doi.org\/10.1016\/S2352-3026(22)00377-5.","journal-title":"Lancet Haematol"},{"issue":"26","key":"1313_CR51","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1182\/blood.2021013536","volume":"138","author":"G Young","year":"2021","unstructured":"Young G. Can we do something about ICH in hemophilia? Blood. 2021;138(26):2750\u20131. https:\/\/doi.org\/10.1182\/blood.2021013536.","journal-title":"Blood."},{"issue":"10","key":"1313_CR52","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00701-004-0347-8","volume":"146","author":"DT Chan","year":"2004","unstructured":"Chan DT, Boet R, Poon WS, Yap F, Chan YL. Spinal shock in spontaneous cervical spinal epidural haematoma. Acta Neurochir. 2004;146(10):1161\u20132; discussion 1162-3. https:\/\/doi.org\/10.1007\/s00701-004-0347-8.","journal-title":"Acta Neurochir"},{"key":"1313_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ca.980040603","volume":"4","author":"RJM Groen","year":"1991","unstructured":"Groen RJM, Ponssen H. Vascular anatomy of the spinal epidural space: Considerations on the etiology of the spontaneous spinal epidural hematoma. Clin Anat. 1991;4:413\u201320. https:\/\/doi.org\/10.1002\/ca.980040603.","journal-title":"Clin Anat"},{"issue":"Suppl 1","key":"1313_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12288-013-0245-4","volume":"30","author":"N Nirupam","year":"2014","unstructured":"Nirupam N, Pemde H, Chandra J. Spinal epidural hematoma in a patient with hemophilia B presenting as acute abdomen. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):54\u20136. https:\/\/doi.org\/10.1007\/s12288-013-0245-4. Epub 2013 Mar 7","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"1313_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3171\/2010.4.PEDS09537","volume":"6","author":"EN Kiehna","year":"2010","unstructured":"Kiehna EN, Waldron PE, Jane JA. Conservative management of an acute spontaneous holocord epidural hemorrhage in a hemophiliac infant. J Neurosurg Pediatr. 2010;6(1):43\u20138. https:\/\/doi.org\/10.3171\/2010.4.PEDS09537.","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"1313_CR56","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/adc.2007.118687","volume":"92","author":"T Kubota","year":"2007","unstructured":"Kubota T, Miyajima Y. Spinal extradural haematoma due to haemophilia A. Arch Dis Child. 2007;92(6):498. https:\/\/doi.org\/10.1136\/adc.2007.118687.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1313_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12887-020-1957-x","volume":"20","author":"A Carlhan-Ledermann","year":"2020","unstructured":"Carlhan-Ledermann A, Laubscher B, Steinlin M, Ulrich CT, Verma RK, Rizzi M, Maduri R, Grunt S. Spinal epidural hematoma without significant trauma in children: two case reports and review of the literature. BMC Pediatr. 2020;20(1):77. https:\/\/doi.org\/10.1186\/s12887-020-1957-x.","journal-title":"BMC Pediatr"},{"issue":"2","key":"1313_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jemermed.2007.02.061","volume":"34","author":"JS Heer","year":"2008","unstructured":"Heer JS, Enriquez EG, Carter AJ. Spinal epidural hematoma as first presentation of hemophilia A. J Emerg Med. 2008;34(2):159\u201362. https:\/\/doi.org\/10.1016\/j.jemermed.2007.02.061.","journal-title":"J Emerg Med"},{"issue":"Suppl 1(Suppl 1","key":"1313_CR59","doi-asserted-by":"publisher","first-page":"s313","DOI":"10.2450\/2012.0111-12","volume":"12","author":"EC Rodriguez-Merchan","year":"2014","unstructured":"Rodriguez-Merchan EC. Peripheral nerve injuries in haemophilia. Blood Transfus. 2014;12(Suppl 1(Suppl 1)):s313\u20138. https:\/\/doi.org\/10.2450\/2012.0111-12.","journal-title":"Blood Transfus"},{"key":"1313_CR60","first-page":"167","volume":"51","author":"SK Saraf","year":"2003","unstructured":"Saraf SK, Singh OP, Singh VP. Peripheral nerve complications in hemophilia. J Assoc Physicians India. 2003;51:167\u20139.","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"1313_CR61","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2516.2009.02141.x","volume":"16","author":"SM Mortazavi","year":"2010","unstructured":"Mortazavi SM, Gilbert RS, Gilbert MS. Cubital tunnel syndrome in patients with haemophilia. Haemophilia. 2010;16(2):333\u20138. https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02141.x.","journal-title":"Haemophilia."},{"key":"1313_CR62","doi-asserted-by":"publisher","first-page":"bcr0320126152","DOI":"10.1136\/bcr-03-2012-6152","volume":"2012","author":"AI Mayne","year":"2012","unstructured":"Mayne AI, Howard A, Kent M, Banks J. Acute carpal tunnel syndrome in a patient with haemophilia. BMJ Case Rep. 2012;2012:bcr0320126152. https:\/\/doi.org\/10.1136\/bcr-03-2012-6152.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1313_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.22038\/abjs.2019.40547.2090","volume":"8","author":"EC Rodriguez-Merchan","year":"2020","unstructured":"Rodriguez-Merchan EC. Hemophilic pseudotumors: diagnosis and management. Arch Bone Jt Surg. 2020;8(2):121\u201330. https:\/\/doi.org\/10.22038\/abjs.2019.40547.2090.","journal-title":"Arch Bone Jt Surg"},{"issue":"3","key":"1313_CR64","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/ijlh.12785","volume":"40","author":"V Nummi","year":"2018","unstructured":"Nummi V, Lassila R, Joutsi-Korhonen L, Armstrong E, Szanto T. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function. Int J Lab Hematol. 2018;40(3):304\u201311. https:\/\/doi.org\/10.1111\/ijlh.12785.","journal-title":"Int J Lab Hematol"},{"key":"1313_CR65","doi-asserted-by":"publisher","first-page":"e936690","DOI":"10.12659\/AJCR.936690","volume":"23","author":"T Koroki","year":"2022","unstructured":"\u2022 Koroki T, Abe T, Kamimura S, Ochiai H. Severe traumatic brain injury in a patient with von Willebrand disease type 2A successfully treated with factor VIII\/von Willebrand factor concentrates: a case report. Am J Case Rep. 2022;23:e936690. https:\/\/doi.org\/10.12659\/AJCR.936690. A recent case report that showed a patient with severe TBI, successfully treated with repeated Factor VIII\/vWF transfusion.","journal-title":"Am J Case Rep"},{"key":"1313_CR66","volume-title":"StatPearls [Internet]","author":"GA Cortes","year":"2023","unstructured":"Cortes GA, Moore MJ, El-Nakeep S. Physiology, von Willebrand factor. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. 2023 Jan\u2013."},{"issue":"3","key":"1313_CR67","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0041-1740566","volume":"48","author":"A Dorgalaleh","year":"2022","unstructured":"\u2022 Dorgalaleh A, Farshi Y, Haeri K, Ghanbari OB, Ahmadi A. Risk and management of intracerebral hemorrhage in patients with bleeding disorders. Semin Thromb Hemost. 2022;48(3):344\u201355. https:\/\/doi.org\/10.1055\/s-0041-1740566. A comprehensive review on pertinent risk factors and management of intracerebral hemorrhage among patients with congenital bleeding disorders.","journal-title":"Semin Thromb Hemost"},{"issue":"9","key":"1313_CR68","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/jth.14886","volume":"18","author":"A Tosetto","year":"2020","unstructured":"\u2022\u2022 Tosetto A, Badiee Z, Baghaipour MR, Baronciani L, Battle J, Berntorp E, et al. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study. J Thromb Haemost. 2020;18(9):2145\u201354. https:\/\/doi.org\/10.1111\/jth.14886. The largest international prospective collaborative registry evaluating the bleeding symptomology in severe type 3 vWD.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1313_CR69","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0037-1613992","volume":"84","author":"JE Sadler","year":"2000","unstructured":"Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84(2):160\u201374.","journal-title":"Thromb Haemost"},{"issue":"14","key":"1313_CR70","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s40265-017-0793-2","volume":"77","author":"JM Heijdra","year":"2017","unstructured":"Heijdra JM, Cnossen MH, Leebeek FWG. Current and emerging options for the management of inherited von Willebrand disease. Drugs. 2017;77(14):1531\u201347. https:\/\/doi.org\/10.1007\/s40265-017-0793-2.","journal-title":"Drugs."},{"issue":"Suppl 1","key":"1313_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2516.2007.01610.x","volume":"14","author":"AB Federici","year":"2008","unstructured":"Federici AB. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007). Haemophilia. 2008;14(Suppl 1):5\u201314. https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01610.x.","journal-title":"Haemophilia."},{"issue":"1","key":"1313_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MBC.0000000000000660","volume":"29","author":"S Tabibian","year":"2018","unstructured":"Tabibian S, Motlagh H, Naderi M, Dorgalaleh A. Intracranial hemorrhage in congenital bleeding disorders. Blood Coagul Fibrinolysis. 2018;29(1):1\u201311. https:\/\/doi.org\/10.1097\/MBC.0000000000000660.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"1313_CR73","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1365-2516.2009.02025.x","volume":"15","author":"AD Metjian","year":"2009","unstructured":"Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM. Konkle BA; HTCN Study Investigators. Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia. 2009;15(4):918\u201325. https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02025.x.","journal-title":"Haemophilia."},{"issue":"4","key":"1313_CR74","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/hae.12142","volume":"19","author":"V Labarque","year":"2013","unstructured":"Labarque V, Stain AM, Blanchette V, Kahr WH, Carcao MD. Intracranial haemorrhage in von Willebrand disease: a report on six cases. Haemophilia. 2013;19(4):602\u20136. https:\/\/doi.org\/10.1111\/hae.12142.","journal-title":"Haemophilia."},{"issue":"4","key":"1313_CR75","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1046\/j.1365-2141.2000.02507.x","volume":"111","author":"M Lak","year":"2000","unstructured":"Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol. 2000;111(4):1236\u20139. https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02507.x.","journal-title":"Br J Haematol"},{"issue":"8","key":"1313_CR76","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","volume":"34","author":"MJ Ariesen","year":"2003","unstructured":"Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060\u20135. https:\/\/doi.org\/10.1161\/01.STR.0000080678.09344.8D.","journal-title":"Stroke."},{"issue":"4","key":"1313_CR77","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/01.STR.0000119382.25543.2A","volume":"35","author":"L Johansson","year":"2004","unstructured":"Johansson L, Jansson JH, Stegmayr B, Nilsson TK, Hallmans G, Boman K. Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case-referent study. Stroke. 2004;35(4):826\u201330. https:\/\/doi.org\/10.1161\/01.STR.0000119382.25543.2A.","journal-title":"Stroke."},{"issue":"3","key":"1313_CR78","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/hae.13451","volume":"24","author":"HCAM Hazendonk","year":"2018","unstructured":"Hazendonk HCAM, Heijdra JM, de Jager NCB, Veerman HC, Boender J, van Moort I. et al; \u201cOPTI-CLOT\u201d and \u201cWIN\u201d study group. Analysis of current perioperative management with Haemate\u00ae P\/Humate P\u00ae in von Willebrand disease: Identifying the need for personalized treatment. Haemophilia. 2018;24(3):460\u201370. https:\/\/doi.org\/10.1111\/hae.13451.","journal-title":"Haemophilia."},{"issue":"4","key":"1313_CR79","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjh.13064","volume":"167","author":"MA Laffan","year":"2014","unstructured":"Laffan MA, Lester W, O'Donnell JS, Will A, Tait RC, Goodeve A, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol. 2014;167(4):453\u201365. https:\/\/doi.org\/10.1111\/bjh.13064.","journal-title":"Br J Haematol"},{"issue":"5","key":"1313_CR80","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jemermed.2020.02.019","volume":"58","author":"C Tebo","year":"2020","unstructured":"Tebo C, Gibson C, Mazer-Amirshahi M. Hemophilia and von Willebrand disease: a review of emergency department management. J Emerg Med. 2020;58(5):756\u201366. https:\/\/doi.org\/10.1016\/j.jemermed.2020.02.019.","journal-title":"J Emerg Med"},{"issue":"12","key":"1313_CR81","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","volume":"29","author":"SG Achinger","year":"2014","unstructured":"Achinger SG, Arieff AI, Kalantar-Zadeh K, Ayus JC. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series. Nephrol Dial Transplant. 2014;29(12):2310\u20135. https:\/\/doi.org\/10.1093\/ndt\/gfu263.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1313_CR82","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1055\/s-0037-1612977","volume":"87","author":"D Lillicrap","year":"2002","unstructured":"Lillicrap D, Poon MC, Walker I, Xie F. Schwartz BA; Association of Hemophilia Clinic Directors of Canada. Efficacy and safety of the factor VIII\/von Willebrand factor concentrate, haemate-P\/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost. 2002;87(2):224\u201330.","journal-title":"Thromb Haemost"},{"issue":"1","key":"1313_CR83","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2516.2008.01901.x","volume":"15","author":"E Berntorp","year":"2009","unstructured":"Berntorp E. Windyga J; European Wilate Study Group. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor\/factor VIII concentrate. Haemophilia. 2009;15(1):122\u201330. https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01901.x.","journal-title":"Haemophilia."},{"issue":"2","key":"1313_CR84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2516.2007.01616.x","volume":"14","author":"GE Rivard","year":"2008","unstructured":"Rivard GE. Aledort L; Alphanate Surgical Investigators. Efficacy of factor VIII\/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery in subjects with von Willebrand disease. Haemophilia. 2008;14(2):271\u20135. https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01616.x.","journal-title":"Haemophilia."},{"issue":"1","key":"1313_CR85","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","volume":"5","author":"NT Connell","year":"2021","unstructured":"\u2022\u2022 Connell NT, Flood VH, Brignardello-Petersen R, Abdul-Kadir R, Arapshian A, Couper S, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021;5(1):301\u201325. https:\/\/doi.org\/10.1182\/bloodadvances.2020003264. American Society of Hematology, International Society on Thrombosis and Hemostasis, National Hemophilia Foundation, World Federation of Hemophilia combined guideline panel outlining recommendations on management of vWD.","journal-title":"Blood Adv"},{"issue":"2","key":"1313_CR86","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","volume":"14","author":"WL Nichols","year":"2008","unstructured":"\u2022\u2022 Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171\u2013232. https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01643.x. The National Heart, Lung and Blood Institute guidelines identifying future research directions in vWD management.","journal-title":"Haemophilia"},{"issue":"4","key":"1313_CR87","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1111\/hae.13742","volume":"25","author":"E Zanon","year":"2019","unstructured":"Zanon E, Pasca S, Bertomoro A, Mardari R, Simioni P. Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: a clinical case and a brief literature review. Haemophilia. 2019;25(4):e282\u20135. https:\/\/doi.org\/10.1111\/hae.13742.","journal-title":"Haemophilia."},{"issue":"17","key":"1313_CR88","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","volume":"126","author":"JC Gill","year":"2015","unstructured":"Gill JC, Castaman G, Windyga J, Kouides P, Ragni M, Leebeek FW, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038\u201346. https:\/\/doi.org\/10.1182\/blood-2015-02-629873.","journal-title":"Blood."},{"issue":"3","key":"1313_CR89","first-page":"387","volume":"88","author":"M Makris","year":"2002","unstructured":"Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand\u2019s disease. Thromb Haemost. 2002;88(3):387\u20138.","journal-title":"Thromb Haemost"},{"issue":"2","key":"1313_CR90","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/blood.v99.2.450","volume":"99","author":"PM Mannucci","year":"2002","unstructured":"Mannucci PM, Chediak J, Hanna W, Byrnes J, Ledford M, Ewenstein BM, Alphanate Study Group, et al. Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study. Blood. 2002;99(2):450\u20136. https:\/\/doi.org\/10.1182\/blood.v99.2.450.","journal-title":"Blood."},{"issue":"3","key":"1313_CR91","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/j.1365-2516.2012.02758.x","volume":"18","author":"A Coppola","year":"2012","unstructured":"Coppola A, Franchini M, Makris M, Santagostino E, Di Minno G, Mannucci PM. Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies. Haemophilia. 2012;18(3):e173\u201387. https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02758.x.","journal-title":"Haemophilia."},{"key":"1313_CR92","doi-asserted-by":"publisher","first-page":"721125","DOI":"10.3389\/fneur.2021.721125","volume":"12","author":"X Jiao","year":"2021","unstructured":"Jiao X, Li M, Li L, Hu X, Guo X, Lu Y. Early tranexamic acid in intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Front Neurol. 2021;12:721125. https:\/\/doi.org\/10.3389\/fneur.2021.721125.","journal-title":"Front Neurol"},{"issue":"2","key":"1313_CR93","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/hae.14687","volume":"29","author":"X Zhang","year":"2023","unstructured":"\u2022 Zhang X, Lewandowska M, Aldridge M, Iglay K, Wolford E, Shapiro A. Global epidemiology of factor XI deficiency: a targeted review of the literature and foundation reports. Haemophilia. 2023;29(2):423\u201334. https:\/\/doi.org\/10.1111\/hae.14687. The latest review with a specific focus on one of the rare factor deficiencies, FXI or hemophilia C.","journal-title":"Haemophilia"},{"issue":"4","key":"1313_CR94","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0029-1225764","volume":"35","author":"S Duga","year":"2009","unstructured":"Duga S, Salomon O. Factor XI Deficiency. Semin Thromb Hemost. 2009;35(4):416\u201325. https:\/\/doi.org\/10.1055\/s-0029-1225764.","journal-title":"Semin Thromb Hemost"},{"issue":"13","key":"1313_CR95","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1182\/blood-2009-09-199182","volume":"115","author":"J Emsley","year":"2010","unstructured":"Emsley J, McEwan PA, Gailani D. Structure and function of factor XI. Blood. 2010;115(13):2569\u201377. https:\/\/doi.org\/10.1182\/blood-2009-09-199182.","journal-title":"Blood."},{"issue":"10","key":"1313_CR96","first-page":"1017","volume":"93","author":"B Khealani","year":"2000","unstructured":"\u2022 Khealani B, Farhat Z, Mozaffar T. Factor XI deficiency-related spontaneous primary intraventricular hemorrhage. South Med J. 2000;93(10):1017\u20138. A case report highlighting the rare occurrence of ICH within a FXI deficient patient.","journal-title":"South Med J"},{"issue":"2","key":"1313_CR97","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000083183","volume":"19","author":"S Brichant","year":"2005","unstructured":"Brichant S, Vokaer M, Beukinga I, De San N, Blecic SA, Kentos A, Bartholom\u00e9 EJ, Bier JC. Cerebellar hemorrhage due to factor XI deficiency. Cerebrovasc Dis. 2005;19(2):138\u20139. https:\/\/doi.org\/10.1159\/000083183.","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"1313_CR98","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1080\/02699052.2020.1807057","volume":"34","author":"EE Espinosa-Rodr\u00edguez","year":"2020","unstructured":"\u2022 Espinosa-Rodr\u00edguez EE, L\u00f3pez-Guti\u00e9rrez M, Tresserras-Gin\u00e9 G, Pesa-Vendrell N, Mart\u00ednez-P\u00e9rez M. First case of delayed traumatic intracerebral hemorrhage in a patient with undiagnosed factor XI deficiency: diagnosis and management review. Brain Inj. 2020;34(11):1541\u20137. https:\/\/doi.org\/10.1080\/02699052.2020.1807057. The most recent case report within the past 5 years elucidating on the management of traumatic ICH in FXI deficiency.","journal-title":"Brain Inj"},{"issue":"Suppl 4(0 4)","key":"1313_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/hae.12402","volume":"20","author":"P James","year":"2014","unstructured":"James P, Salomon O, Mikovic D, Peyvandi F. Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia. 2014;20(Suppl 4(0 4)):71\u20135. https:\/\/doi.org\/10.1111\/hae.12402.","journal-title":"Haemophilia"},{"issue":"3","key":"1313_CR100","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-0037-1604109","volume":"44","author":"SER Alavi","year":"2018","unstructured":"Alavi SER, Jalalvand M, Assadollahi V, Tabibian S, Dorgalaleh A. Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders-prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency. Semin Thromb Hemost. 2018;44(3):267\u201375. https:\/\/doi.org\/10.1055\/s-0037-1604109.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"1313_CR101","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0041-1740566","volume":"48","author":"A Dorgalaleh","year":"2022","unstructured":"Dorgalaleh A, Farshi Y, Haeri K, Ghanbari OB, Ahmadi A. Risk and management of intracerebral hemorrhage in patients with bleeding disorders. Semin Thromb Hemost. 2022;48(3):344\u201355. https:\/\/doi.org\/10.1055\/s-0041-1740566.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"1313_CR102","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12185-014-1664-1","volume":"100","author":"M Naderi","year":"2014","unstructured":"Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M, Bamedi T. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol. 2014;100(5):443\u20139. https:\/\/doi.org\/10.1007\/s12185-014-1664-1.","journal-title":"Int J Hematol"},{"issue":"10","key":"1313_CR103","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s10072-015-2284-0","volume":"36","author":"G Ribizzi","year":"2015","unstructured":"Ribizzi G, Farinini D, Gentile R, Rizzi D, Serrati C. Factor XIII deficiency and head trauma: management and therapy. Neurol Sci. 2015;36(10):1933\u20134. https:\/\/doi.org\/10.1007\/s10072-015-2284-0.","journal-title":"Neurol Sci"},{"key":"1313_CR104","doi-asserted-by":"publisher","unstructured":"Saes JL, Schols SEM, van Heerde WL, Nijziel MR. Hemorrhagic disorders of fibrinolysis: a clinical review. J Thromb Haemost. 2018; https:\/\/doi.org\/10.1111\/jth.14160.","DOI":"10.1111\/jth.14160"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-023-01313-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T07:35:37Z","timestamp":1700811337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-023-01313-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":104,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s11910-023-01313-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,21]]},"assertion":[{"value":"15 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Muhammad Qasim Bhatti, Ezekiel Gonzalez-Fernandez, Kunal Bhatia, Afshin A. Divani, Mario Di Napoli, Archana Hinduja, and Yvonne H. Datta each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}